Sutter Opens New Center In Sacramento To Expand Capacity For Senior Care
“We expect to serve about 1,000 with the new facility,” Phil Chuang, vice president of strategy for Sutter, tells the Sacramento Bee. In other industry news: Pfizer's hospital-drug problems and how immigration impacts the doctor shortage.
Sutter Expands To Serve More Of Sacramento’s Frailest Seniors
The Sutter health care team that serves the Sacramento region’s frailest senior citizens on Tuesday opened a $11.6 million center that will allow staff to care for roughly three times the patients now seen in two smaller facilities. ...The new Sutter facility, at 444 N. Third St. in Sacramento’s River District, is part of a federal health initiative known as PACE, Program of All-Inclusive Care for the Elderly, that treats the whole person rather than their set of medical conditions. (Anderson, 10/30)
Pfizer’s Hospital-Drug Problems Won’t Go Away
Buying Hospira was supposed to open a bright new pharmaceutical future for Pfizer Inc., but problems from the company’s past keep haunting the world’s largest drugmaker. When Pfizer agreed to pay $17 billion to take over Hospira in 2015, the deal was presented as a bet on biosimilars -- cheaper versions of brand-name biologic medications that could steal the thunder from some of Pfizer’s rivals’ biggest products. The move would position Pfizer as the biggest player in a burgeoning medical marketplace. (Koons, Langreth and Edney, 10/30)
Immigration Rhetoric Stokes Fears Of Doctor Shortages
The Trump administration’s actions and rhetoric on immigration are stoking fears among physician training experts that fewer foreign doctors will want to train and serve in the United States, where they make up a significant portion of a medical workforce that is already short-handed. The commission that certifies graduates of foreign medical schools who come here for their residencies says it is seeing a decrease in the number of people applying from foreign countries affected by Trump’s executive actions on immigrations. Its leaders worry that promising students or doctors from other countries will also think twice about whether to continue their medical training in the U.S. (Siddons, 10/30)